Clinical Trial Update: DK222 Study at Hopkins [Phase 1]

View source ↗

Summary

This document provides a status update on the Phase 1 DK222 study at Johns Hopkins, which is currently recruiting. The trial targets non-small cell lung cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Urothelial Cancer

Drugs mentioned

• DK222

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Non-Small Cell Lung Cancer, Urothelial Cancer | Phase 1 | Status: RECRUITING